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Medical Management of Portal Hypertension
The physician's role in the treatment of portal hypertension may be considered under three headings: The emergency management of bleeding varices, the decision to seek surgical co-operation, whether emergency or elective, and finally the treatment of the various post-operative complications.
Treatment ofBleeding Varices
Morphia must be avoided if there is liver disease as therapeutic doses can induce precoma in some patients with cirrhosis ). All sedatives are dangerous but if the patient is very restless, but not precomatose, small doses of phenobarbitone or amylobarbitone sodium will probably be tolerated.
The hemoglobin level is maintained by slow transfusion given through plastic tubing threaded into a large vein. Two litres of compatible blood should always be available, but if possible fresh blood should be used, for this may partly correct deficiencies of clotting factors (Finkbiner et' al. 1959) . Bleeding from cesophageal varices is liable to recur and particular care must be taken to preserve veins and in cross-matching blood so that subsequent transfusions may not produce reactions.
The patient with cirrhosis should be treated as for incipient coma with glucose only and neomycin 6 g daily by mouth (Sherlock 1961) . Neurological complications may thus be avoided.
If the bleeding continues in hospital more active measures must be used.
The three-lumened Sengstaken cesophageal compression tube may be introduced. Local pressure on the cesophageal varices is applied by the cesophageal balloon while the gastric balloon obstructs the submucosal veins of the fundus, through which the cesophageal varices are supplied. The third lumen enters the stomach and should be wide enough so that blood clots may be withdrawn through it. Unfortunately, the method has numerous complications, particularly oesophageal ulceration which was noted in 13 of 38 intubations in one series (Read et al. 1960 ). This usually, but not constantly, complicates prolonged or repeated introductions.
In view of the disadvantages of the Sengstaken tube a drug is needed which will lower portal venous pressure without reducing systemic blood pressure. Posterior pituitary extract is known to lower the portal venous pressure in animals by constriction of the splanchnic arteriolar bed, causing an increase in resistance to the inflow of blood to the gut (McMichael 1932) . Vasopressin undoubtedly controls hemorrhage from cesophageal varices by lowering portal blood pressure (Kehne et al. 1956 , Schwartz et al. 1959 , Shaldon & Sherlock 1960 .
Twenty units vasopressin are given intravenously in ten minutes. Main arterial pressure rises transiently and portal pressure falls for threequarters to one hour. Side-effects include pallor, colicky abdominal discomfort and evacuation of the bowel. If these changes are not seen the vasopressin is probably inactive and a fresh batch should be tried. Vasopressin is a coronary artery constrictor and should not be given if there is a history of angina or if the ECG shows evidence of myocardial ischemia. Cessation of hemorrhage presumably results from the temporary reduction in portal pressure, allowing hemostasis at the bleeding point. Re-bleeding, however, is not uncommon and the ultimate failure of repeated doses to control terminal recurrent hemorrhage reflects the degree of liver failure rather than the method of treatment. Vasopressin treatment should now be used in preference to cesophageal tamponade.
Emergency Surgery This is usually considered in the patient who bleeds repeatedly after initial control by the cesophageal compression tube or by vasopressin infusions. The decision to operate in the individual patient is very difficult. The patient in whom control of bleeding is hardest is likely to be the one with the worst liver cell function. In such subjects the mortality is high with or without surgical intervention. -Trans-splenic portal venography should precede operation.
Elective Surgery Portacaval anastomosis, either end-to-side or sideto-side, is the only operation offering permanent cure of portal hypertension. Splenorenal anastomosis usually provides too small a shunt for effective reduction of portal pressure.
Patients selected should be in good general condition and preferably less than 40 years old; older patients develop neuropsychiatric changes more readily than younger ones .
Portal hypertension should have been established. Splenic venography must have shown patency of the portal vein. At least one hoemorrhage should have occurred from proven varices. The place of prophylactic shunting (Sullivan et al. 1960) has not yet been evaluated fully. Serum bilirubin should be less than 1 5 mg/ 100 ml and serum albumin greater than 3 g/100 ml. Alcoholics do better than non-alcoholics if they can be persuaded to abstain.
Section ofSurgery
Effects ofPortacaval Anastomosis If an effective portacaval shunt is produced there is no further gastrointestinal bleeding from varices. Abdominal wall collaterals disappear. The spleen diminishes in size. Within six months to one year, barium swallow shows disappearance of varices and on cesophagoscopy they appear white and collapsed.
Splenic venography confirms the patent shunt. Hepatic blood flow is reduced (Redeker et al. 1958) . The oxygen supply to the liver cells is maintained by better extraction of oxygen, the arterialhepatic vein oxygen difference increasing. In the case of end-to-side anastomosis the liver is now supplied solely by the hepatic artery. Intra-splenic pressure falls; rise in pressure means that the anastomosis is blocked (Atkinson & Sherlock 1954) .
In the end-to-side portacaval anastomosis the wedged (post-sinusoidal) hepatic venous pressure falls with the hepatic blood flow; the ratio, i.e. post-sinusoidal vascular resistance, is unchanged, indicating that the outflow block has not been relieved. This is emphasized by observations in patients with side-to-side anastomosis where the sinusoidal pressure exceeds that in the free portal vein which now becomes the outflow tract of the liver (Warren & Muller 1959) .
The long-term effect of the complete diversion of portal blood and diminished liver blood flow is uncertain. Certainly the liver size becomes less but serial liver function tests show only the changes expected in cirrhotics without surgical intervention.
Jaundice is likely to deepen immediately, due to the effects on the liver of the operation and to the increased bilirubin load contained in blood transfusions. A more specific hyperbilirubinaemia of unknown etiology due to unconjugated pigment but not to hemolysis is also said to develop (Da Silva et al. 1960) .
(Edema of the ankles develops or increases in most patients with cirrhosis if the anastomosis is successful. Pressure in the inferior vena cava does not increase. The cedema is presumably part of the general fluid retention of cirrhosis. The portal pressure has been reduced but the serum albumin remains low, so fluid localizes in dependent parts rather than in the peritoneal cavity.
Neuropsychiatric complications: The new large channel allows nitrogenous substances to pass from the portal into the systemic veins. If the amounts are greater than can be metabolized by the liver, the symptoms of portal systemic encephalopathy (episodic stupor) may ensue. These may be only transient in the post-operative period when liver cell function is depressed. Chronic changes, however, can also be anticipated. Seven of 21 patients who satisfied the usual criteria of selection for the operation subsequently had neuropsychiatric complications. In addition 5 others showed symptomless EEG abnormalities and 2 others an EEG which became abnormal under the stress of high protein feeding. Only 6 of the 21 had maintained a normal clinical state and normal EEG .
Patients who show the greatest deterioration of hepatocellular function are the most likely to develop neuropsychiatric changes. This may be due to the nature of the underlying cirrhosis, the operation merely serving to keep the patient alive long enough for liver failure to develop. The progressive course is more common in the cryptogenic and post-infective type than in the cirrhosis of alcoholics where arrest can follow abstention. Symptoms are commoner in older patients, perhaps due to the changes in the ageing brain which make it less capable of meeting alterations in its environment .
The possibility must be faced that even patients with no history of precoma who can tolerate protein well and have a normal EEG may develop this change. Very few patients have the same intellectual performance as previously. This makes the decision about the advisability of performing the anastomosis a difficult one. Particularly can this be so where high intellectual performance is normally required.
These changes do not develop after splenorenal anastomosis, for the shunt is not sufficiently large.
Gastric function: In dogs, portacaval anastomosis is followed by gastric hypersecretion (Clarke 1960) . Portal vein histamine level exceeds that in the hepatic vein or femoral artery. Plasma histamine after a meal rises higher in dogs with a portacaval anastomosis than in normal animals. The post-shunt hypersecretion is therefore said to be due to histamine by-passing the action of hepatic histaminase. This may lead to peptic ulceration, which developed in 150% of patients after the operation (McDermott et al. 1961 ).
The leucopenia, thrombocytopenia and anwmia are unaffected if the spleen is left in situ.
Septica?mia, usually Gram-negative, occasionally follows entry of intestinal organisms into the systemic veins through the shunt.
Chronic spastic paraplegia has been reported in 2 cases (Zieve et al. 1960 ). Autopsy in one showed demyelination of the pyramidal tracts in the spinal cord.
Conclusions
The problem of the surgical treatment of portal hypertension has not been solved. In the cirrhotic group very few patients ha, e sufficiently adequate liver function to allow the procedure with the greatest hope of success (portacaval anastomosis). This operation, moreover, is highly specialized and could only be performed by a team trained in such procedures. The patient with cirrhosis whose only complaint is recurrent hematemesis may achieve a spectacularly good result. Surgical procedures, however, treat only the mechanical effect of portal vein obstruction and the prognosis remains that of hepatocellular function. The problem of hemorrhage in patients with poor liver function remains.
In the group with extrahepatic portal obstruction, prognosis, even without surgery, is good provided adequate blood transfusion is available.
It can be said of all the procedures described that adequate follow-ups have not yet been made. A laparotomy per se often provides relief from bleeding for a time. Moreover, medical measures such as bed rest and a good diet alone are often followed by a fall in portal pressure especially in alcoholic subjects who lose fat from the liver. This makes assessment of the results of surgery even more difficult.
